Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.1 AUD | -0.74% | +5.46% | -19.50% |
04-24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
04-23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.50% | 1.71B | |
+33.43% | 700B | |
+27.45% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.98% | 236B | |
+6.70% | 202B | |
-9.41% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada